Literature DB >> 30398622

An iTRAQ-Based Quantitative Proteomic Analysis of Plasma Proteins in Preterm Newborns With Retinopathy of Prematurity.

Magdalena Zasada1, Maciej Suski2, Renata Bokiniec3, Monika Szwarc-Duma3, Maria Katarzyna Borszewska-Kornacka3, Józef Madej2, Beata Bujak-Gizycka2, Anna Madetko-Talowska4, Cecilie Revhaug5, Lars O Baumbusch5, Ola D Saugstad5, Jacek Józef Pietrzyk1, Przemko Kwinta1.   

Abstract

Purpose: Retinopathy of prematurity (ROP) is a vision-threatening complication of a premature birth, in which the etiology still remains unclear. Importantly, the molecular processes that govern these effects can be investigated in a perturbed plasma proteome composition. Thus, plasma proteomics may add new insights into a better understanding of the pathogenesis of this disease.
Methods: The cord and peripheral blood of neonates (≤30 weeks gestational age) was drawn at birth and at the 36th postmenstrual week (PMA), respectively. Blood samples were retrospectively subdivided into ROP(+) and ROP(-) groups, according to the development of ROP.
Results: The quantitative analysis of plasma proteome at both time points revealed 30 protein abundance changes between ROP(+) and ROP(-) groups. After standardization to gestational age, children who developed ROP were characterized by an increased C3 complement component and fibrinogen level at both analyzed time points. Conclusions: Higher levels of the complement C3 component and fibrinogen, present in the cord blood and persistent to 36 PMA, may indicate a chronic low-grade systemic inflammation and hypercoagulable state that may play a role in the development of ROP.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30398622     DOI: 10.1167/iovs.18-24914

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Comparative two time-point proteome analysis of the plasma from preterm infants with and without bronchopulmonary dysplasia.

Authors:  Magdalena Zasada; Maciej Suski; Renata Bokiniec; Monika Szwarc-Duma; Maria Katarzyna Borszewska-Kornacka; Józef Madej; Beata Bujak-Giżycka; Anna Madetko-Talowska; Cecilie Revhaug; Lars O Baumbusch; Ola D Saugstad; Jacek Józef Pietrzyk; Przemko Kwinta
Journal:  Ital J Pediatr       Date:  2019-08-24       Impact factor: 2.638

Review 2.  The use of proteomics for blood biomarker research in premature infants: a scoping review.

Authors:  Natasha Letunica; Tengyi Cai; Jeanie L Y Cheong; Lex W Doyle; Paul Monagle; Vera Ignjatovic
Journal:  Clin Proteomics       Date:  2021-04-14       Impact factor: 3.988

3.  Targeted Blood Metabolomic Study on Retinopathy of Prematurity.

Authors:  Yuhang Yang; Zhenquan Wu; Sitao Li; Mingmin Yang; Xin Xiao; Chaohui Lian; Wei Wen; Honghui He; Jian Zeng; Jiantao Wang; Guoming Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

4.  Plasma levels of amino acids and derivatives in retinopathy of prematurity.

Authors:  Yedi Zhou; Yu Xu; Xiang Zhang; Qian Huang; Wei Tan; Yonghui Yang; Xiaori He; Shigeo Yoshida; Peiquan Zhao; Yun Li
Journal:  Int J Med Sci       Date:  2021-08-27       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.